Repository logo

Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol

Loading...
Thumbnail Image

Advisor

Coadvisor

Graduate program

Undergraduate course

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Type

Article

Access right

Acesso restrito

Abstract

Flavopiridol has been shown to potently inhibit CDK1 and 2 (cyclin-dependent kinases 1 and 2) and most recently it has been found that it also inhibits CDK9. The complex CDK9-cyclin T1 controls the elongation phase of transcription by RNA polymerase II. The present work describes a molecular model for the binary complex CDK9-flavopiridol. This structural model indicates that the inhibitor strongly binds to the ATP-binding pocket of CDK9 and the structural comparison of the complex CDK2-flavopiridol correlates the structural differences with differences in inhibition of these CDKs by flavopiridol. This structure opens the possibility of testing new inhibitor families, in addition to new substituents for the already known leading structures such as flavones and adenine derivatives. © 2002 Elsevier Science (USA). All rights reserved.

Description

Language

English

Citation

Biochemical and Biophysical Research Communications, v. 293, n. 1, p. 566-571, 2002.

Sponsors

Related publications

Units

Item type:Unit,

Departments

Undergraduate courses

Graduate programs